Cantor Fitzgerald initiated coverage on Sorrento Therapeutics with a new price target

11/2/22 6:29:52 AM ET

Biotechnology: Commercial Physical & Biological Resarch

Health Care

Cantor Fitzgerald initiated coverage of Sorrento Therapeutics with a rating of Overweight and set a new price target of $5.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$SRNE

Date	Price Target	Rating	Analyst
11/2/2022	$5.00	Overweight	Cantor Fitzgerald
8/9/2021	$30.00 → $26.00	Buy	HC Wainwright & Co.